Total Funding
36
10
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
354820
Synapse Biomedical offers NeuRx Diaphragm Pacing System (DPS)® which uses neurostimulation technology to help spinal cord injuries.
James E. Gelbke: Director of Advanced ManufacturingPast Role: NeuroControl Corporation, Held Several Manufacturing Positions
Timothy Crish: V.P. of Product Development & OperationsPast Role: Axon Engineering Inc, Held Various Engineering Positions in Product Development
About the Company
Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)® that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of
the art of electrical stimulation for the treatment of chronic respiratory insufficiency.
